Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1515 of 5804
-
Could a clotting booster cut blood loss in ICU patients?
Disease control Recruiting nowAssessment of high-normal dosage of Wilate ® compared to placebo administered in combination with platelets to assess reduction of amount of blood loss, need of transfusion products and outcome (length of stay, mortality) in patients with bleeding in comparison.
Phase: PHASE4 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Heart attack diagnosis gets a Sex-Specific upgrade: new study could save Women's lives
Diagnosis CompletedAcute myocardial infarction (MI) is defined as a rise and/or fall in cardiac troponins (cTn) with at least one value above the 99th percentile upper reference limit (URL) in the context of symptoms or clinical evidence of myocardial ischemia. The URL is based on measurements in a…
Phase: NA • Sponsor: Herlev Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Robotic arm brace could restore movement in chronic stroke patients
Symptom relief Recruiting nowThis study will evaluate the effects of combining motor learning-based therapy with use of the MyoPro , a wearable exoskeletal myoelectrically controlled orthotic device. MyoPro uses electromyographic (EMG) signals from the weak muscles to assist movement of the user's affected a…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New MRI technique could catch osteoarthritis years earlier
Diagnosis Recruiting nowCurrently the diagnosis of OA is based on radiographs and clinical findings, which is limited to detecting late-stage disease. There is a pressing, unmet clinical need for robust assessment of early changes in cartilage health. Towards this goal, extensive efforts are ongoing to …
Sponsor: Xiaojuan Li • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
New therapy targets sleep and daily rhythms to fight teen suicide
Symptom relief CompletedThe purpose of this study is to advance a non-pharmacologic suicide preventive intervention with wide dissemination potential as an innovative high-yield solution to reduce suicide rates. The investigators aim to achieve this with this study of Brain Emotion Circuitry Self-Monito…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Peer-Led events could help more black men start HIV prevention
Prevention Recruiting nowThe goal of the proposed research is to design a peer-based community intervention focused on addressing HIV stigma, and peer support to increase PrEP initiation in Prince George's County, MD. Participants will attend intervention events focused on stigma reduction and building c…
Phase: NA • Sponsor: George Mason University • Aim: Prevention
Last updated Jun 27, 2026 07:52 UTC
-
Can a cancer drug help heart transplant patients get a match?
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to learn about how well the drug daratumumab/hyaluronidase-fihj (DARZALEX Faspro™) helps to lower high levels of HLA (Human Leukocyte Antigen) antibodies in a person waiting for a heart transplant.
Phase: PHASE2 • Sponsor: Barry A. Boilson • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New combo therapy aims to wipe out breast cancer before surgery
Disease control Recruiting nowThis is an prospective, multicenter, single-arm clinical study.
Phase: PHASE4 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New study tests better ways to link former inmates to HIV and addiction treatment
Disease control CompletedThis is a 5-year Hybrid Type 1 Effectiveness-Implementation Randomized Control Trial (RCT) that compares two models of linking and retaining individuals recently released from justice involvement to the continuum of community-based HIV prevention and treatment, HCV treatment, STI…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New study offers hope for parents struggling with grief after Child's cancer death
Symptom relief Recruiting nowThe purpose of this study is to compare three types of support programs for parents who have lost a child. The study will see how these support programs affect participants' grief and depression symptoms. The three support programs are called Meaning-Centered Grief Therapy, Suppo…
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Gut bacteria capsules take on superbugs in antibiotic patients
Disease control CompletedRandomized, placebo-controlled trial to evaluate the safety and efficacy of oral intestinal microbiota capsules for decolonizing multidrug-resistant organisms (MDROs) and Clostridioides difficile in patients requiring prolonged antibiotic therapy. The primary outcome was clearanc…
Phase: PHASE1, PHASE2 • Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New antibody drug could reduce infusions for nerve disorder
Disease control CompletedThis is a phase 2, randomized, double-blinded, placebo-controlled, parallel-group, multicenter trial to evaluate the safety and efficacy of 2 dose regimens of ARGX-117 versus placebo, in participants with MMN previously stabilized with IVIg (intravenous immunoglobulin).
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Balloon brachytherapy aims to stop esophageal cancer recurrence without surgery
Disease control OngoingClinical experience of adding intraluminal brachytherapy with traditional applicator after definitive concurrent chemoradiotherapy (CCRT) for local-regional thoracic esophageal cancer is limited due to high complication risk and non-superiority in survival. The innovative applica…
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug combo aims to fight tough pancreatic cancer
Disease control Recruiting nowThe purpose of this study is to assess the safety, tolerability and efficacy of JPI-547 in combination with modified FOLFIRINOX (mFOLFIRINOX) or Gemcitabine-nab-paclitaxel (GemAbraxne) in patients with locally advanced and metastatic pancreatic cancer
Phase: PHASE1, PHASE2 • Sponsor: Onconic Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Clopidogrel may stop 'Silent' strokes that lead to dementia
Prevention OngoingSilent brain infarctions (SBIs) are a manifestation of covert cerebrovascular disease, without obvious clinical deficit, noted very often in patients presenting with a new stroke or new transient ischemic attack. SBIs are linked to a significant increase in risk for subsequent st…
Phase: PHASE4 • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Robotic arm could help people with paralysis regain independence at home
Symptom relief CompletedFor all individuals deprived of active and functional motor control of the upper limbs to perform grasping tasks, the restoration of a grasping function becomes a priority. The population concerned is mainly represented by so-called functional tetraplegic individuals. In this c…
Phase: NA • Sponsor: Association APPROCHE • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Custom-Made vaccine plus immunotherapy shows promise in tough lung cancer
Disease control OngoingThe investigators hypothesize that a personalized neoantigen vaccine combined with durvalumab will improve the progression free survival of patients with extensive state small cell lung cancer (ES-SCLC).
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Experimental drug aims to boost thinking skills in teens with fragile x
Symptom relief CompletedThis is a 2-part study, with each part having a unique set of objectives for male adolescents aged 9 to \< 18 years with fragile X syndrome (FXS). Part 1 is an open-label, single-dose, pharmacokinetics (PK) assessment of BPN14770 25 mg and 50 mg, while Part 2 is double-blind (DB)…
Phase: PHASE2, PHASE3 • Sponsor: Tetra Discovery Partners • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
One and done? new study tests single-dose radiation boost for breast cancer
Disease control CompletedThe ULTIMO trial is a monocentric, prospective, randomised controlled, open-label, phase III interventional clinical trial, with a non-inferiority design, in patients with breast cancer undergoing breast conservative treatment (BCT). After giving informed consent and verifying el…
Phase: PHASE3 • Sponsor: Cancer Research Antwerp • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New brain scan could spot Alzheimer's earlier
Diagnosis Recruiting nowThe goal of this project is to quantify brain fibrin content using 64Cu-FBP8-PET in the brains of subjects ranging from cognitively normal to clinically diagnosed with ADRD to evaluate potential regional differences.
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC